Dave S B Hoon Selected Research

Cell-Free Nucleic Acids

1/2022	Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy.
1/2020	Simultaneous Isolation of Circulating Nucleic Acids and EV-Associated Protein Biomarkers From Unprocessed Plasma Using an AC Electrokinetics-Based Platform.
1/2018	Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring Disease.
11/2017	Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence.
2/2017	LINE-1 hypomethylation status of circulating cell-free DNA in plasma as a biomarker for colorectal cancer.
1/2017	Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
1/2015	Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.
1/2014	Epigenetic biomarkers in skin cancer.
11/2013	Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.
9/2011	Prognostic molecular biomarkers for cutaneous malignant melanoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dave S B Hoon Research Topics

Disease

115	Neoplasms (Cancer) 05/2022 - 01/2002
98	Melanoma (Melanoma, Malignant) 05/2022 - 03/2002
48	Neoplasm Metastasis (Metastasis) 01/2022 - 10/2002
24	Breast Neoplasms (Breast Cancer) 01/2020 - 12/2002
14	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 12/2002
13	Circulating Neoplastic Cells 01/2022 - 02/2006
8	Adenoma (Adenomas) 01/2018 - 10/2004
7	Disease Progression 01/2018 - 04/2003
6	Triple Negative Breast Neoplasms 01/2022 - 05/2012
6	Neoplasm Micrometastasis 09/2012 - 10/2003
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 11/2018
4	Lymphatic Metastasis 01/2020 - 12/2002
4	Carcinogenesis 01/2020 - 07/2005
3	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 03/2009
3	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2017
3	Glioma (Gliomas) 01/2020 - 01/2016
3	Carcinoma (Carcinomatosis) 06/2011 - 01/2002
2	Hypoxia (Hypoxemia) 01/2022 - 04/2003
2	COVID-19 01/2022 - 01/2022
2	Hepatocellular Carcinoma (Hepatoma) 02/2015 - 01/2002
2	Rectal Neoplasms (Rectal Cancer) 11/2014 - 05/2008
2	Cutaneous Malignant Melanoma 09/2011 - 01/2010
2	Lung Neoplasms (Lung Cancer) 01/2009 - 01/2002
2	Stomach Neoplasms (Stomach Cancer) 11/2007 - 01/2002
2	Colonic Neoplasms (Colon Cancer) 10/2007 - 01/2002
2	Hypersensitivity (Allergy) 01/2006 - 03/2002

Drug/Important Bio-Agent (IBA)

48	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2004
33	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2004
31	Messenger RNA (mRNA)IBA 01/2020 - 01/2002
29	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
22	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2004
19	ParaffinIBA 05/2022 - 10/2003
16	AntigensIBA 02/2022 - 03/2002
15	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2004
14	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2022 - 12/2002
13	MicroRNAs (MicroRNA)IBA 05/2022 - 05/2009
8	Chemokine ReceptorsIBA 05/2017 - 04/2004
6	Circulating MicroRNAIBA 01/2021 - 10/2015
6	VaccinesIBA 11/2018 - 03/2002
6	SoilIBA 12/2015 - 05/2006
6	Estrogen ReceptorsIBA 12/2014 - 03/2005
6	Calcibiotic Root Canal SealerIBA 11/2010 - 12/2002
5	ChromatinIBA 01/2022 - 12/2014
5	Biological ProductsIBA 01/2022 - 01/2009
5	Pharmaceutical PreparationsIBA 01/2021 - 03/2003
5	LigandsIBA 05/2017 - 07/2006
5	Circulating Tumor DNAIBA 03/2016 - 01/2004
4	AntibodiesIBA 01/2022 - 04/2006
4	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 12/2002
4	Histones (Histone)IBA 01/2018 - 11/2012
4	Small Interfering RNA (siRNA)IBA 01/2017 - 11/2005
4	MART-1 AntigenIBA 01/2014 - 01/2003
4	ChemokinesIBA 05/2010 - 04/2005
3	Formaldehyde (Formol)FDA Link 05/2022 - 01/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2013
3	UbiquitinIBA 04/2020 - 07/2013
3	NucleotidesIBA 01/2018 - 06/2012
3	Histone Deacetylase InhibitorsIBA 06/2017 - 03/2003
3	sodium bisulfite FDA Link 12/2015 - 05/2007
3	ErbB Receptors (EGF Receptor)IBA 07/2013 - 03/2005
3	CanvaxinIBA 02/2012 - 10/2002
3	Hematoxylin (Haematoxylon)IBA 06/2011 - 09/2004
3	Eosine Yellowish-(YS) (Eosin)IBA 06/2011 - 09/2004
3	Nucleic AcidsIBA 06/2011 - 06/2004
3	HMW-MAAIBA 02/2010 - 06/2008
3	Immunoglobulin G (IgG)IBA 12/2006 - 03/2002
3	dopachrome isomeraseIBA 12/2006 - 10/2003
3	Monophenol Monooxygenase (Tyrosinase)IBA 10/2003 - 01/2003
2	Macrophage Migration-Inhibitory FactorsIBA 05/2022 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 10/2015
2	Lysine (L-Lysine)FDA Link 09/2021 - 05/2012
2	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2020 - 01/2020
2	Ligases (Synthetase)IBA 04/2020 - 08/2017
2	GangliosidesIBA 01/2020 - 06/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2010
2	matrigelIBA 01/2018 - 04/2006
2	Phenobarbital (Luminal)FDA Link 01/2018 - 12/2014
2	Phosphotransferases (Kinase)IBA 11/2017 - 03/2004
2	AngiopoietinsIBA 09/2017 - 09/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 10/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2015 - 10/2015
2	Claudin-1IBA 03/2015 - 09/2012
2	EnzymesIBA 11/2014 - 09/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2012 - 11/2007
2	MethyltransferasesIBA 05/2012 - 03/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2009 - 11/2008
2	Peptides (Polypeptides)IBA 01/2009 - 12/2006
2	Genetic Markers (Genetic Marker)IBA 09/2006 - 04/2003
2	Complementary DNA (cDNA)IBA 07/2006 - 04/2006
2	SurvivinIBA 12/2005 - 11/2005
2	Combined VaccinesIBA 12/2005 - 10/2002

Therapy/Procedure

34	Therapeutics 01/2022 - 10/2002
15	Immunotherapy 01/2022 - 03/2002
9	Lymph Node Excision (Lymph Node Dissection) 01/2018 - 10/2002
5	Precision Medicine 01/2019 - 01/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 03/2004
4	Lasers (Laser) 04/2011 - 01/2002
2	Radiotherapy 12/2014 - 03/2004
2	Biological Therapy 04/2010 - 12/2006